AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

Jun 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-06-01

Reporting Person: Gershkowitz Jayne (SVP, Chief Patient Advocate)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-01	Stock Options (right to buy)	$12.28	A	50000	Acquired	2025-06-01	Common Stock (50000)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 1, 2016. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2016, with the final installment vesting on June 1, 2019.